IL5 and asthma: Notably, no direct head-to-head comparisons between anti-IL-5 antibodies in asthma have been made, although one head-to-head study comparing benralizumab and mepolizumab in Eosinophilic Granulomatosis With Polyangiitis is ongoing (MANDARA) (126).